ajmaline/asthenia

A report is given on a patient in whom during treatment and prophylactic measures of paroxysmal tachycardias after intravenous application of ajmalin large attacks of fever with chills developed. The oral application evoked subfebrile temperatures and weakness. The drug-fever which was to be

Brugada syndrome is a disease characterized by a specific electrocardiographic pattern and an increased risk of sudden cardiac death. We present this case with the updated literature to emphasise the need to consider the diagnosis of Brugada syndrome in patients admitted to the emergency ward with

Recurrent supraventricular arrhythmias are associated with palpitations, weakness, syncopes, etc. Pharmacological treatment with antiarrhythmic agents aims to interrupt the tachyarrhythmia episodes (acute therapy) and to stabilize sinus rhythm thereafter (chronic therapy). Due to the newer curative